HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Dichloromethotrexate

HCID 10713
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
528-74-5
Standard SMILES
CN(Cc1cnc2nc(N)nc(N)c2n1)c1c(Cl)cc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1Cl
InChIKey
MCEHFIXEKNKSRW-LBPRGKRZSA-N
Molecular formula
C20H20Cl2N8O5
Average molar mass
523.3 g/mol
Monoisotopic mass
522.0933712

Overview

Dichloromethotrexate appears as light yellow or yellow powder. (NTP, 1992)

Names & identifiers

Preferred name
Dichloromethotrexate
IUPAC
(2S)-2-[[3,5-dichloro-4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid
English name
Dichloromethotrexate
Molecular formula
C20H20Cl2N8O5
Molecular weight
523.33

Names & synonyms

DICHLOROMETHOTREXATE528-74-5Dichloroamethopterin3',5'-DichloromethotrexateMethotrexate, dichloro-3,5-DichloromethotrexateNSC 296303',5'-DichloroamethopterinNSC-29630Amethopterin, 3',5'-dichloro-NCI-C04875DTXSID3024996
Show more names
Aids006949NCI-C-04875Aids-0069493988-B-129-43',5'-Dichloroaminopterin
29NS58S4653',5'-Dichloro-4-amino-4-deoxy-N(sup 10)-methylpteroglutamic acidNSC29630Glutamic acid, N-(3,5-dichloro-4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-Glutamic acid, N-(3,5-dichloro-4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-, L-L-Glutamic acid, N-(3,5-dichloro-4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-L-Glutamic acid, N-[3,5-dichloro-4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-Glutamic acid, N-[3,5-dichloro-4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, L-

Database identifiers

CAS
528-74-5
PubChem CID
10713
DTXSID

Properties

Computed structural properties

XLogP
-0.1
Topological polar surface area
211 Ų
Hydrogen bond donors
5
Hydrogen bond acceptors
12
Rotatable bonds
9
Heavy atoms
35
Formal charge
0
Complexity
770

Experimental & physicochemical properties

LogP0.33
Solubilityless than 1 mg/mL at 72 °F (NTP, 1992)
Physical DescriptionDichloromethotrexate appears as light yellow or yellow powder. (NTP, 1992)

Physicochemical properties

Density
1.9183 · 1.9183 (rough estimate)
refractive index
1.735 · 1.7350 (estimate)
pka
3.44 · 3.44±0.10(Predicted)
FDA UNII
29 NS58S465 · 29NS58S465
NCI Drug Dictionary
dichloromethotrexate
EPA Substance Registry System
3 · 3',5'-Dichloromethotrexate (528-74-5)
Toxicity
50 intraperitoneal · LD50 intraperitoneal in mouse: 655mg/kg

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Hazard information

Fire HazardsFlash point data for this compound are not available. It is probably combustible. (NTP, 1992)
Health HazardsACUTE/CHRONIC HAZARDS: When heated to decomposition this compound emits toxic fumes. (NTP, 1992)
Reactive GroupAcids, Carboxylic
Air and Water ReactionsInsoluble in water.

Safety & protection

Fire FightingFires involving this material can be controlled with a dry chemical, carbon dioxide or Halon extinguisher. (NTP, 1992)
First Aid · 1 item

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Nonfire Spill Response · 1 item

SMALL SPILLS AND LEAKAGE: If you spill this chemical, FIRST REMOVE ALL SOURCES OF IGNITION, then dampen the solid spill material with toluene, then transfer the dampened material to a suitable container. Use absorbent paper dampened with toluene to pick up any remaining material. Your contaminated clothing and absorbent paper should be sealed in a vapor-tight plastic bag for eventual disposal. Solvent-wash all contaminated surfaces with toluene followed by washing with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 2 items

Substances that inhibit or prevent the proliferation of NEOPLASMS.

Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033)

Applications

General DescriptionLight yellow or yellow powder.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
DTXSID3024996
ChEMBL
CHEMBL3137680
UNII
29NS58S465
Nikkaji
J9.434J
Personal Protective Equipment (PPE) · 1 item

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with a combination filter cartridge, i.e. organic vapor/acid gas/HEPA (specific for organic vapors, HCl, acid gas, SO2 and a high efficiency particulate filter). (NTP, 1992)

Safety data

Toxicity
LD50 intraperitoneal in mouse: 655mg/kg